TrialScientific reports2016

The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma.

Chao Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.